Nuveen’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $300M | Sell |
5,212,215
-601,418
| -10% | -$34.5M | 0.07% | 204 |
|
|
2026
Q1 | $353M | Buy |
5,813,633
+287,372
| +5% | +$16.8M | 0.1% | 168 |
|
|
2025
Q4 | $298M | Sell |
5,526,261
-473,495
| -8% | -$22.8M | 0.08% | 198 |
|
|
2025
Q3 | $271M | Sell |
5,999,756
-321,605
| -5% | -$15M | 0.07% | 223 |
|
|
2025
Q2 | $293M | Sell |
6,321,361
-3,915,868
| -38% | -$192M | 0.08% | 207 |
|
|
2025
Q1 | $624M | Sell |
10,237,229
-183,716
| -2% | -$10.7M | 0.19% | 99 |
|
|
2024
Q4 | $589M | Buy |
10,420,945
+1,444,822
| +16% | +$80.7M | 0.17% | 107 |
|
|
2024
Q3 | $464M | Buy |
8,976,123
+3,434,182
| +62% | +$161M | 0.13% | 139 |
|
|
2024
Q2 | $230M | Sell |
5,541,941
-4,407,780
| -44% | -$197M | 0.07% | 227 |
|
|
2024
Q1 | $540M | Sell |
9,949,721
-756,035
| -7% | -$38.5M | 0.16% | 121 |
|
|
2023
Q4 | $549M | Sell |
10,705,756
-644,574
| -6% | -$33.8M | 0.18% | 111 |
|
|
2023
Q3 | $659M | Sell |
11,350,330
-3,653,431
| -24% | -$224M | 0.23% | 96 |
|
|
2023
Q2 | $959M | Sell |
15,003,761
-1,330,078
| -8% | -$89.2M | 0.33% | 64 |
|
|
2023
Q1 | $1.13B | Sell |
16,333,839
-1,257,704
| -7% | -$88.7M | 0.42% | 51 |
|
|
2022
Q4 | $1.27B | Buy |
17,591,543
+968,998
| +6% | +$73.1M | 0.49% | 44 |
|
|
2022
Q3 | $1.18B | Buy |
16,622,545
+865,053
| +5% | +$62.8M | 0.48% | 38 |
|
|
2022
Q2 | $1.21B | Buy |
15,757,492
+2,226,874
| +16% | +$170M | 0.47% | 40 |
|
|
2022
Q1 | $961M | Buy |
13,530,618
+410,317
| +3% | +$27.6M | 0.31% | 64 |
|
|
2021
Q4 | $818M | Sell |
13,120,301
-884,926
| -6% | -$51.9M | 0.24% | 89 |
|
|
2021
Q3 | $829M | Sell |
14,005,227
-723,903
| -5% | -$47.7M | 0.26% | 83 |
|
|
2021
Q2 | $984M | Buy |
14,729,130
+328,973
| +2% | +$21.5M | 0.29% | 70 |
|
|
2021
Q1 | $909M | Sell |
14,400,157
-157,862
| -1% | -$9.82M | 0.29% | 70 |
|
|
2020
Q4 | $903M | Buy |
14,558,019
+1,365,694
| +10% | +$84M | 0.31% | 64 |
|
|
2020
Q3 | $795M | Sell |
13,192,325
-34,499
| -0.3% | -$2.08M | 0.31% | 69 |
|
|
2020
Q2 | $778M | Sell |
13,226,824
-4,992,608
| -27% | -$299M | 0.32% | 68 |
|
|
2020
Q1 | $1.02B | Sell |
18,219,432
-3,091,390
| -15% | -$189M | 0.49% | 38 |
|
|
2019
Q4 | $1.37B | Buy |
21,310,822
+11,327,720
| +113% | +$649M | 0.52% | 33 |
|
|
2019
Q3 | $506M | Buy |
9,983,102
+587,982
| +6% | +$27.6M | 0.2% | 101 |
|
|
2019
Q2 | $426M | Buy |
9,395,120
+9,332,319
| +14,860% | +$435M | 0.17% | 122 |
|
|
2019
Q1 | $3M | Buy |
62,801
+8,059
| +15% | +$401K | 0.02% | 583 |
|
|
2018
Q4 | $2.85M | Buy |
54,742
+182
| +0.3% | +$9.78K | 0.02% | 571 |
|
|
2018
Q3 | $3.39M | Sell |
54,560
-1,395
| -2% | -$82.8K | 0.02% | 566 |
|
|
2018
Q2 | $3.1M | Sell |
55,955
-40,922
| -42% | -$2.21M | 0.02% | 546 |
|
|
2018
Q1 | $6.13M | Sell |
96,877
-157,239
| -62% | -$10.1M | 0.04% | 459 |
|
|
2017
Q4 | $15.6M | Buy |
254,116
+191,370
| +305% | +$12M | 0.1% | 303 |
|
|
2017
Q3 | $4M | Hold |
62,746
| – | – | 0.03% | 509 |
|
|
2017
Q2 | $3.5M | Sell |
62,746
-26,533
| -30% | -$1.44M | 0.02% | 530 |
|
|
2017
Q1 | $4.86M | Sell |
89,279
-127,979
| -59% | -$7.02M | 0.03% | 518 |
|
|
2016
Q4 | $12.7M | Buy |
217,258
+13,961
| +7% | +$763K | 0.06% | 387 |
|
|
2016
Q3 | $11M | Sell |
203,297
-3,116
| -2% | -$200K | 0.06% | 365 |
|
|
2016
Q2 | $15.2M | Sell |
206,413
-9,500
| -4% | -$671K | 0.09% | 265 |
|
|
2016
Q1 | $13.8M | Sell |
215,913
-9,206
| -4% | -$581K | 0.07% | 280 |
|
|
2015
Q4 | $15.5M | Buy |
225,119
+34,099
| +18% | +$2.25M | 0.08% | 258 |
|
|
2015
Q3 | $11.3M | Sell |
191,020
-5,441
| -3% | -$345K | 0.06% | 308 |
|
|
2015
Q2 | $13.1M | Sell |
196,461
-24,913
| -11% | -$1.64M | 0.07% | 326 |
|
|
2015
Q1 | $14.3M | Buy |
221,374
+1,327
| +0.6% | +$83.1K | 0.08% | 326 |
|
|
2014
Q4 | $13M | Buy |
220,047
+100,297
| +84% | +$5.66M | 0.07% | 340 |
|
|
2014
Q3 | $6.13M | Sell |
119,750
-197,082
| -62% | -$9.84M | 0.04% | 482 |
|
|
2014
Q2 | $15.4M | Sell |
316,832
-134,271
| -30% | -$6.62M | 0.09% | 286 |
|
|
2014
Q1 | $23.4M | Buy |
451,103
+55,997
| +14% | +$2.98M | 0.14% | 190 |
|
|
2013
Q4 | $21M | Sell |
395,106
-14,524
| -4% | -$740K | 0.14% | 220 |
|
|
2013
Q3 | $19M | Sell |
409,630
-44,959
| -10% | -$1.97M | 0.12% | 227 |
|
|
2013
Q2 | $20.3M | Buy |
+454,589
| New | +$19.7M | 0.14% | 211 |
|
Other funds holding BMY
Nuveen's BMY Position: Q2 2026 in Review
Nuveen reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q2 2026, selling an estimated $34.5M and leaving 5,212,215 shares worth $300M. The position accounts for 0.07% of the portfolio, ranked #204.
Nuveen first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.37B in Q4 2019. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Nuveen held 5,212,215 shares of Bristol-Myers Squibb worth $300M as of Q2 2026.
- Nuveen sold 601,418 Bristol-Myers Squibb shares in Q2 2026, an estimated $34.5M.
- Bristol-Myers Squibb made up 0.07% of Nuveen's portfolio in Q2 2026, its #204 holding.
- Nuveen first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Bristol-Myers Squibb position peaked at $1.37B in Q4 2019.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.